Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Tetrahydropyran-based thiodisaccharide mimics as Galectin-3 inhibitors

Tetrahydropyran-based thiodisaccharide mimics as Galectin-3 inhibitors

US Patent 11970511 · Granted Apr 30, 2024

Estimated economic value: $459,497,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

1H-benzo[D]imidazole derivatives as TLR9 inhibitors for the treatment of fibrosi2025
Imidazo[1,2-A]pyridine and [1,2,4]triazolo[1,5-A]pyridine derivatives as TLR9 in2025
Heterocyclic PAD4 inhibitors2025
Galectin-3 inhibitors2025
Small molecule inhibitors of galectin-32025
Small molecule inhibitors of galectin-32025
Tricyclic heteroaryl compounds useful as IRAK4 inhibitors2025
Small molecule inhibitors of galectin-32025
Small molecule inhibitors of galectin-32025
Small molecule inhibitors of galectin-32025
Small molecule inhibitors of galectin-32025
Small molecule inhibitors of galectin-32025